US 9676840
Anti-CD100 neutralizing antibodies and methods of using the same
granted A61KA61K2039/505A61K38/1774
Quick answer
US patent 9676840 (Anti-CD100 neutralizing antibodies and methods of using the same) held by VACCINEX, INC. expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/505, A61K38/1774, A61K39/0001, A61K39/3955